Standout Papers

Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with... 2017 2026 2020 2023 379
  1. Pretreatment neutrophil-to-lymphocyte ratio as a marker of outcomes in nivolumab-treated patients with advanced non-small-cell lung cancer (2017)
    Stephen Bagley, Shawn Kothari et al. Lung Cancer

Immediate Impact

9 from Science/Nature 58 standout
Sub-graph 1 of 22

Citing Papers

Precision nanomedicine: navigating the tumor microenvironment for enhanced cancer immunotherapy and targeted drug delivery
2025 Standout
Advances in cancer immunotherapy: historical perspectives, current developments, and future directions
2025 Standout
2 intermediate papers

Works of Stephen Bagley being referenced

Small-molecule toosendanin reverses macrophage-mediated immunosuppression to overcome glioblastoma resistance to immunotherapy
2023
CAR T-cell therapy for glioblastoma: recent clinical advances and future challenges
2018
and 2 more

Author Peers

Author Last Decade Papers Cites
Stephen Bagley 583 963 289 457 98 1.9k
Patrick Healy 368 948 136 503 98 1.9k
Seema Nagpal 995 810 321 1033 127 3.0k
Matteo Simonelli 784 678 376 793 128 2.4k
Matthias Holdhoff 799 589 340 334 109 2.0k
Clark C. Chen 676 573 191 558 126 2.6k
Helen Wheeler 1337 663 323 581 109 2.5k
Siham Sabri 388 584 362 327 55 2.0k
Serena Desideri 1090 673 143 362 68 2.6k
Rimas V. Lukas 755 501 145 540 114 1.8k
Kevin A. Walter 744 438 187 368 63 2.1k

All Works

Loading papers...

Rankless by CCL
2026